Unique Therapy
for Unique People
Since its inception in 2008, BioGenCell has been committed to transforming the lives of patients with degenerative diseases through advanced cell therapy treatments, based on the Company’s groundbreaking TRACT technology that uses a patient’s own blood as personalized medicine.
Our
Mission
A Future of Possibilities Starts with Clinical Research
Our mission is to make personalized cell therapy a reality for patients worldwide, providing accessible treatments to various unmet needs. Our innovative TRACT technology allows for stem cell therapies that are patient-friendly and physician-friendly.
Making Personalized Cell Therapy a Reality
Through advanced, standardized procedures, we are dedicated to bringing transformative cell therapy treatments to vascular physicians and surgeons, podiatrists, and various other healthcare providers and clinicians.
Dive deeper into the uniqueness of our TRACT solution
Easily
Standardized
Accessible
Tailored to
Patients’ Needs
Dedicated and Passionate Team and Advisors
Meet the people behind BioGenCell: A Group of Dedicated BioMed, Healthcare, Vascular and Business Professionals, Including a Nobel Prize Laureate and World-Renowned Scientists.
Management Team
Board of Directors
Expert Advisors
Prof. Aaron Ciechanover ,MD
Nobel Prize Laureate, Research Prof., Technion Faculty of Medicine
Prof. Martin Grajower, MD
Clinical Associate Prof. of Medicine, Albert Einstein College of Medicine
Prof. Michael Belkin, MD
Former Chair of Ophthalmology, Founder & Director, the Eye Research Institute at TAU
Joseph L. Mills, Sr., MD
Reid Prof., Chief of the Division of Vascular Surgery and Endovascular Therapy, Baylor College of Medicine
We Are Committed to Improving Lives
By advancing the field of personalized cell therapy using the patient’s own blood, we aim to enhance the safety and efficacy of treatments, and their accessibility and affordability. This enables us to tackle the world’s deadliest diseases and meet the needs of physicians and patients alike.